{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:17:13Z","timestamp":1789510633447,"version":"build-2803163510"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-2110-1","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T13:27:33Z","timestamp":1533216453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Improving glycemic control in critically ill patients: personalized care to mimic the endocrine pancreas"],"prefix":"10.1186","volume":"22","author":[{"given":"J. Geoffrey","family":"Chase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Desaive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Cnop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"De Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Hovorka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Kalfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Krinsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Preiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"2110_CR1","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","volume":"373","author":"KM Dungan","year":"2009","unstructured":"Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373:1798\u2013807.","journal-title":"Lancet"},{"key":"2110_CR2","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s00134-004-2167-y","volume":"30","author":"PE Marik","year":"2004","unstructured":"Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30:748\u201356.","journal-title":"Intensive Care Med"},{"key":"2110_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1164\/rccm.201212-2228ED","volume":"187","author":"TW Rice","year":"2013","unstructured":"Rice TW. Gluttony in the intensive care unit: time to push back from the consensus table. Am J Respir Crit Care Med. 2013;187:223\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"2110_CR4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2337\/dc16-0008","volume":"39","author":"E Renard","year":"2016","unstructured":"Renard E, Farret A, Kropff J, Bruttomesso D, Messori M, Place J, et al. Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home. Diabetes Care. 2016;39:1151\u201360.","journal-title":"Diabetes Care"},{"key":"2110_CR5","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/cc6868","volume":"12","author":"JG Chase","year":"2008","unstructured":"Chase JG, Shaw G, Le Compte A, Lonergan T, Willacy M, Wong XW, et al. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care. 2008;12:R49.","journal-title":"Crit Care"},{"key":"2110_CR6","doi-asserted-by":"publisher","first-page":"R154","DOI":"10.1186\/cc9224","volume":"14","author":"JG Chase","year":"2010","unstructured":"Chase JG, Pretty CG, Pfeifer L, Shaw GM, Preiser JC, Le Compte AJ, et al. Organ failure and tight glycemic control in the SPRINT study. Crit Care. 2010;14:R154.","journal-title":"Crit Care"},{"key":"2110_CR7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G van den Berghe","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359\u201367.","journal-title":"N Engl J Med"},{"key":"2110_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa052521","volume":"354","author":"G van den Berghe","year":"2006","unstructured":"van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449\u201361.","journal-title":"N Engl J Med"},{"key":"2110_CR9","doi-asserted-by":"publisher","first-page":"992","DOI":"10.4065\/79.8.992","volume":"79","author":"JS Krinsley","year":"2004","unstructured":"Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992\u20131000.","journal-title":"Mayo Clin Proc"},{"key":"2110_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125\u201339.","journal-title":"N Engl J Med"},{"key":"2110_CR11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"S Finfer","year":"2009","unstructured":"Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283\u201397.","journal-title":"N Engl J Med"},{"key":"2110_CR12","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1007\/s00134-009-1585-2","volume":"35","author":"JC Preiser","year":"2009","unstructured":"Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738\u201348.","journal-title":"Intensive Care Med"},{"key":"2110_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00134-013-3189-0","volume":"40","author":"P Kalfon","year":"2014","unstructured":"Kalfon P, Giraudeau B, Ichai C, Guerrini A, Brechot N, Cinotti R, et al. Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial. Intensive Care Med. 2014;40:171\u201381.","journal-title":"Intensive Care Med"},{"key":"2110_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13054-017-1725-y","volume":"21","author":"V Uyttendaele","year":"2017","unstructured":"Uyttendaele V, Dickson JL, Shaw GM, Desaive T, Chase JG. Untangling glycaemia and mortality in critical care. Crit Care. 2017;21:152.","journal-title":"Crit Care"},{"key":"2110_CR15","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","volume":"42","author":"SE Kahn","year":"1993","unstructured":"Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663\u201372.","journal-title":"Diabetes"},{"key":"2110_CR16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/ana.23698","volume":"72","author":"M Cnop","year":"2012","unstructured":"Cnop M, Igoillo-Esteve M, Rai M, Begu A, Serroukh Y, Depondt C, et al. Central role and mechanisms of beta-cell dysfunction and death in friedreich ataxia-associated diabetes. Ann Neurol. 2012;72:971\u201382.","journal-title":"Ann Neurol"},{"key":"2110_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1210\/jc.2004-1133","volume":"90","author":"E Ferrannini","year":"2005","unstructured":"Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2005;90:493\u2013500.","journal-title":"J Clin Endocrinol Metab"},{"key":"2110_CR18","first-page":"E241","volume":"257","author":"L Luzi","year":"1989","unstructured":"Luzi L, DeFronzo RA. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Phys. 1989;257:E241\u20136.","journal-title":"Am J Phys"},{"key":"2110_CR19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.2337\/dc08-1826","volume":"32","author":"A Basu","year":"2009","unstructured":"Basu A, Dalla MC, Basu R, Toffolo G, Cobelli C, Rizza RA. Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care. 2009;32:866\u201372.","journal-title":"Diabetes Care"},{"key":"2110_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ng.2383","volume":"44","author":"AP Morris","year":"2012","unstructured":"Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981\u201390.","journal-title":"Nat Genet"},{"key":"2110_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/1566524053766004","volume":"5","author":"B Ahren","year":"2005","unstructured":"Ahren B. Type 2 diabetes, insulin secretion and beta-cell mass. Curr Mol Med. 2005;5:275\u201386.","journal-title":"Curr Mol Med"},{"key":"2110_CR22","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1177\/1932296816648713","volume":"10","author":"JC Preiser","year":"2016","unstructured":"Preiser JC, Chase JG, Hovorka R, Joseph JI, Krinsley JS, De Block C, et al. Glucose control in the ICU: a continuing story. J Diabetes Sci Technol. 2016;10:1372\u201381.","journal-title":"J Diabetes Sci Technol"},{"key":"2110_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13054-017-1784-0","volume":"21","author":"JS Krinsley","year":"2017","unstructured":"Krinsley JS, Chase JG, Gunst J, Martensson J, Schultz MJ, Taccone FS, et al. Continuous glucose monitoring in the ICU: clinical considerations and consensus. Crit Care. 2017;21:197.","journal-title":"Crit Care"},{"key":"2110_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2337\/dc09-9029","volume":"32","author":"ES Moghissi","year":"2009","unstructured":"Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32:1119\u201331.","journal-title":"Diabetes Care"},{"key":"2110_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13054-015-0908-7","volume":"19","author":"JS Krinsley","year":"2015","unstructured":"Krinsley JS, Preiser JC. Time in blood glucose range 70 to 140 mg\/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults. Crit Care. 2015;19:179.","journal-title":"Crit Care"},{"key":"2110_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jcrc.2014.12.013","volume":"30","author":"S Penning","year":"2015","unstructured":"Penning S, Pretty C, Preiser JC, Shaw GM, Desaive T, Chase JG. Glucose control positively influences patient outcome: a retrospective study. J Crit Care. 2015;30:455\u20139.","journal-title":"J Crit Care"},{"key":"2110_CR27","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1177\/193229681200600506","volume":"6","author":"M Signal","year":"2012","unstructured":"Signal M, Le Compte A, Shaw GM, Chase JG. Glycemic levels in critically ill patients: are normoglycemia and low variability associated with improved outcomes? J Diabetes Sci Technol. 2012;6:1030\u20137.","journal-title":"J Diabetes Sci Technol."},{"key":"2110_CR28","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.2337\/dc13-1771","volume":"37","author":"T Okabayashi","year":"2014","unstructured":"Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Tokumaru T, Iiyama T, et al. Intensive versus intermediate glucose control in surgical intensive care unit patients. Diabetes Care. 2014;37:1516\u201324.","journal-title":"Diabetes Care"},{"key":"2110_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2110-5820-1-11","volume":"1","author":"JG Chase","year":"2011","unstructured":"Chase JG, Le Compte AJ, Preiser JC, Shaw GM, Penning S, Desaive T. Physiological modeling, tight glycemic control, and the ICU clinician: what are models and how can they affect practice? Ann Intensive Care. 2011;1:11.","journal-title":"Ann Intensive Care"},{"key":"2110_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/193229680800200310","volume":"2","author":"JG Chase","year":"2008","unstructured":"Chase JG, Andreassen S, Jensen K, Shaw GM. Impact of human factors on clinical protocol performance: a proposed assessment framework and case examples. J Diabetes Sci Technol. 2008;2:409\u201316.","journal-title":"J Diabetes Sci Technol."},{"key":"2110_CR31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4037\/ajcc2006.15.4.370","volume":"15","author":"D Aragon","year":"2006","unstructured":"Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15:370\u20137.","journal-title":"Am J Crit Care"},{"key":"2110_CR32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/193229681300700129","volume":"7","author":"T Okabayashi","year":"2013","unstructured":"Okabayashi T, Kozuki A, Sumiyoshi T, Shima Y. Technical challenges and clinical outcomes of using a closed-loop glycemic control system in the hospital. J Diabetes Sci Technol. 2013;7:238\u201346.","journal-title":"J Diabetes Sci Technol."},{"key":"2110_CR33","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1186\/cc7114","volume":"12","author":"S Eslami","year":"2008","unstructured":"Eslami S, de Keizer NF, de Jonge E, Schultz MJ, Abu-Hanna A. A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset. Crit Care. 2008;12:R139.","journal-title":"Crit Care"},{"key":"2110_CR34","volume-title":"Modelling methodology for physiology and medicine","author":"ER Carson","year":"2001","unstructured":"Carson ER, Cobelli C. Modelling methodology for physiology and medicine. Amsterdam: Elsevier; 2001."},{"key":"2110_CR35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/193229680700100306","volume":"1","author":"T Van Herpe","year":"2007","unstructured":"Van Herpe T, Espinoza M, Haverbeke N, Moor BD, van den Berghe G. Glycemia prediction in critically ill patients using an adaptive modeling approach. J Diabetes Sci Technol. 2007;1:348\u201356.","journal-title":"J Diabetes Sci Technol."},{"key":"2110_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cmpb.2009.06.004","volume":"97","author":"U Pielmeier","year":"2010","unstructured":"Pielmeier U, Andreassen S, Nielsen BS, Chase JG, Haure P. A simulation model of insulin saturation and glucose balance for glycemic control in ICU patients. Comput Methods Prog Biomed. 2010;97:211\u201322.","journal-title":"Comput Methods Prog Biomed"},{"key":"2110_CR37","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1088\/0967-3334\/29\/8\/008","volume":"29","author":"R Hovorka","year":"2008","unstructured":"Hovorka R, Chassin LJ, Ellmerer M, Plank J, Wilinska ME. A simulation model of glucose regulation in the critically ill. Physiol Meas. 2008;29:959\u201378.","journal-title":"Physiol Meas"},{"key":"2110_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cmpb.2010.12.008","volume":"102","author":"J Lin","year":"2011","unstructured":"Lin J, Razak NN, Pretty CG, Le Compte A, Docherty P, Parente JD, et al. A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients. Comput Methods Prog Biomed. 2011;102:192\u2013205.","journal-title":"Comput Methods Prog Biomed"},{"key":"2110_CR39","doi-asserted-by":"crossref","unstructured":"Dickson JL, Stewart KW, Pretty CG, Flechet M, Desaive T, Penning S, et al. Generalisability of a virtual trials method for glycaemic control in intensive care. IEEE Trans Biomed Eng. 2018;65:1543\u20131553.","DOI":"10.1109\/TBME.2017.2686432"},{"key":"2110_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/193229680900300106","volume":"3","author":"BP Kovatchev","year":"2009","unstructured":"Kovatchev BP, Breton M, Man CD, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3:44\u201355.","journal-title":"J Diabetes Sci Technol."},{"key":"2110_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/edrv-6-1-45","volume":"6","author":"RN Bergman","year":"1985","unstructured":"Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1985;6:45\u201386.","journal-title":"Endocr Rev"},{"key":"2110_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2337\/dc12-0584","volume":"36","author":"T Van Herpe","year":"2013","unstructured":"Van Herpe T, Mesotten D, Wouters PJ, Herbots J, Voets E, Buyens J, et al. LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: the LOGIC-1 single-center, randomized, controlled clinical trial. Diabetes Care. 2013;36:188\u201394.","journal-title":"Diabetes Care"},{"key":"2110_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13054-017-1799-6","volume":"21","author":"J Dubois","year":"2017","unstructured":"Dubois J, Van Herpe T, van Hooijdonk RT, Wouters R, Coart D, Wouters P, et al. Software-guided versus nurse-directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial. Crit Care. 2017;21:212.","journal-title":"Crit Care"},{"key":"2110_CR44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0169-2607(00)00069-9","volume":"62","author":"T Arleth","year":"2000","unstructured":"Arleth T, Andreassen S, Federici MO, Benedetti MM. A model of the endogenous glucose balance incorporating the characteristics of glucose transporters. Comput Methods Prog Biomed. 2000;62:219\u201334.","journal-title":"Comput Methods Prog Biomed"},{"key":"2110_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jcrc.2009.10.003","volume":"25","author":"U Pielmeier","year":"2010","unstructured":"Pielmeier U, Andreassen S, Juliussen B, Chase JG, Nielsen BS, Haure P. The Glucosafe system for tight glycemic control in critical care: a pilot evaluation study. J Crit Care. 2010;25:97\u2013104.","journal-title":"J Crit Care"},{"key":"2110_CR46","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1210\/jc.2007-0434","volume":"92","author":"R Hovorka","year":"2007","unstructured":"Hovorka R, Kremen J, Blaha J, Matias M, Anderlova K, Bosanska L, et al. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab. 2007;92:2960\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"2110_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1475-925X-9-84","volume":"9","author":"JG Chase","year":"2010","unstructured":"Chase JG, Suhaimi F, Penning S, Preiser JC, Le Compte AJ, Lin J, et al. Validation of a model-based virtual trials method for tight glycemic control in intensive care. Biomed Eng Online. 2010;9:84.","journal-title":"Biomed Eng Online"},{"key":"2110_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/dia.2006.8.191","volume":"8","author":"T Lonergan","year":"2006","unstructured":"Lonergan T, Le Compte A, Willacy M, Chase JG, Shaw GM, Wong XW, et al. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther. 2006;8:191\u2013206.","journal-title":"Diabetes Technol Ther"},{"key":"2110_CR49","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1109\/TBME.2012.2214384","volume":"59","author":"LM Fisk","year":"2012","unstructured":"Fisk LM, Le Compte AJ, Shaw GM, Penning S, Desaive T, Chase JG. STAR development and protocol comparison. IEEE Trans Biomed Eng. 2012;59:3357\u201364.","journal-title":"IEEE Trans Biomed Eng"},{"key":"2110_CR50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13613-016-0125-9","volume":"6","author":"KW Stewart","year":"2016","unstructured":"Stewart KW, Pretty CG, Tomlinson H, Thomas FL, Homlok J, Noemi SN, et al. Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis. Ann Intensive Care. 2016;6:24.","journal-title":"Ann Intensive Care"},{"key":"2110_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/193229680800200311","volume":"2","author":"ME Wilinska","year":"2008","unstructured":"Wilinska ME, Chassin LJ, Hovorka R. In silico testing\u2014impact on the progress of the closed loop insulin infusion for critically ill patients project. J Diabetes Sci Technol. 2008;2:417\u201323.","journal-title":"J Diabetes Sci Technol."},{"key":"2110_CR52","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/1932296817693254","volume":"11","author":"SL Wendt","year":"2017","unstructured":"Wendt SL, Ranjan A, Moller JK, Schmidt S, Knudsen CB, Holst JJ, et al. Cross-validation of a glucose-insulin-glucagon pharmacodynamics model for simulation using data from patients with type 1 diabetes. J Diabetes Sci Technol. 2017;11:1101\u201311.","journal-title":"J Diabetes Sci Technol."},{"key":"2110_CR53","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1089\/dia.2016.0128","volume":"18","author":"R Visentin","year":"2016","unstructured":"Visentin R, Giegerich C, Jager R, Dahmen R, Boss A, Grant M, et al. Improving efficacy of inhaled technosphere insulin (Afrezza) by postmeal dosing: in-silico clinical trial with the University of Virginia\/Padova type 1 diabetes simulator. Diabetes Technol Ther. 2016;18:574\u201385.","journal-title":"Diabetes Technol Ther"},{"key":"2110_CR54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/193229681200600223","volume":"6","author":"SS Kanderian","year":"2012","unstructured":"Kanderian SS, Weinzimer SA, Steil GM. The identifiable virtual patient model: comparison of simulation and clinical closed-loop study results. J Diabetes Sci Technol. 2012;6:371\u20139.","journal-title":"J Diabetes Sci Technol."},{"key":"2110_CR55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1089\/dia.2011.0016","volume":"13","author":"ME Wilinska","year":"2011","unstructured":"Wilinska ME, Blaha J, Chassin LJ, Cordingley JJ, Dormand NC, Ellmerer M, et al. Evaluating glycemic control algorithms by computer simulations. Diabetes Technol Ther. 2011;13:713\u201322.","journal-title":"Diabetes Technol Ther"},{"key":"2110_CR56","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1109\/TBME.2016.2535241","volume":"63","author":"R Visentin","year":"2016","unstructured":"Visentin R, Man CD, Cobelli C. One-day Bayesian cloning of type 1 diabetes subjects: toward a single-day UVA\/Padova type 1 diabetes simulator. IEEE Trans Biomed Eng. 2016;63:2416\u201324.","journal-title":"IEEE Trans Biomed Eng"},{"key":"2110_CR57","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cmpb.2011.08.007","volume":"109","author":"AJ Le Compte","year":"2013","unstructured":"Le Compte AJ, Pretty CG, Lin J, Shaw GM, Lynn A, Chase JG. Impact of variation in patient response on model-based control of glycaemia in critically ill patients. Comput Methods Prog Biomed. 2013;109:211\u20139.","journal-title":"Comput Methods Prog Biomed"},{"key":"2110_CR58","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cmpb.2010.11.006","volume":"102","author":"JG Chase","year":"2011","unstructured":"Chase JG, Le Compte AJ, Suhaimi F, Shaw GM, Lynn A, Lin J, et al. Tight glycemic control in critical care\u2014the leading role of insulin sensitivity and patient variability: a review and model-based analysis. Comput Methods Prog Biomed. 2011;102:156\u201371.","journal-title":"Comput Methods Prog Biomed"},{"key":"2110_CR59","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4158\/EP161402.OR","volume":"23","author":"RJ Tanenberg","year":"2017","unstructured":"Tanenberg RJ, Hardee S, Rothermel C, Drake AJ III. Use of a computer-guided glucose management system to improve glycemic control and address national quality measures: a 7-year, retrospective observational study at a tertiary care teaching hospital. Endocr Pract. 2017;23:331\u201341.","journal-title":"Endocr Pract"},{"key":"2110_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1472-6947-5-38","volume":"5","author":"M Vogelzang","year":"2005","unstructured":"Vogelzang M, Zijlstra F, Nijsten MW. Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit. BMC Med Inform Decis Mak. 2005;5:38.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2110_CR61","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.2337\/diacare.28.10.2418","volume":"28","author":"PC Davidson","year":"2005","unstructured":"Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005;28:2418\u201323.","journal-title":"Diabetes Care"},{"key":"2110_CR62","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1089\/dia.2012.0277","volume":"15","author":"MR Marvin","year":"2013","unstructured":"Marvin MR, Inzucchi SE, Besterman BJ. Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin. Diabetes Technol Ther. 2013;15:246\u201352.","journal-title":"Diabetes Technol Ther"},{"key":"2110_CR63","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/193229680800200307","volume":"2","author":"R Juneja","year":"2008","unstructured":"Juneja R, Golas AA, Carroll J, Nelson D, Abad VJ, Roudebush CP, et al. Safety and effectiveness of a computerized subcutaneous insulin program to treat inpatient hyperglycemia. J Diabetes Sci Technol. 2008;2:384\u201391.","journal-title":"J Diabetes Sci Technol."},{"key":"2110_CR64","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/cc3981","volume":"10","author":"S Meijering","year":"2006","unstructured":"Meijering S, Corstjens AM, Tulleken JE, Meertens JH, Zijlstra JG, Ligtenberg JJ. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care. 2006;10:R19.","journal-title":"Crit Care"},{"key":"2110_CR65","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4158\/EP11260.OR","volume":"18","author":"S Shetty","year":"2012","unstructured":"Shetty S, Inzucchi SE, Goldberg PA, Cooper D, Siegel MD, Honiden S. Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: the updated Yale insulin infusion protocol. Endocr Pract. 2012;18:363\u201370.","journal-title":"Endocr Pract"},{"key":"2110_CR66","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1089\/dia.2009.0147","volume":"12","author":"K Amrein","year":"2010","unstructured":"Amrein K, Ellmerer M, Hovorka R, Kachel N, Parcz D, Korsatko S, et al. Hospital glucose control: safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients. Diabetes Technol Ther. 2010;12:405\u201312.","journal-title":"Diabetes Technol Ther"},{"key":"2110_CR67","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12871-016-0175-4","volume":"16","author":"J Blaha","year":"2016","unstructured":"Blaha J, Barteczko-Grajek B, Berezowicz P, Charvat J, Chvojka J, Grau T, et al. Space GlucoseControl system for blood glucose control in intensive care patients\u2014a European multicentre observational study. BMC Anesthesiol. 2016;16:8.","journal-title":"BMC Anesthesiol"},{"key":"2110_CR68","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2337\/dc08-1851","volume":"32","author":"J Blaha","year":"2009","unstructured":"Blaha J, Kopecky P, Matias M, Hovorka R, Kunstyr J, Kotulak T, et al. Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care. 2009;32:757\u201361.","journal-title":"Diabetes Care"},{"key":"2110_CR69","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00134-008-1033-8","volume":"34","author":"C Pachler","year":"2008","unstructured":"Pachler C, Plank J, Weinhandl H, Chassin LJ, Wilinska ME, Kulnik R, et al. Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients. Intensive Care Med. 2008;34:1224\u201330.","journal-title":"Intensive Care Med"},{"key":"2110_CR70","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/2110-5820-1-38","volume":"1","author":"A Evans","year":"2011","unstructured":"Evans A, Shaw GM, Le Compte A, Tan CS, Ward L, Steel J, et al. Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control. Ann Intensive Care. 2011;1:38.","journal-title":"Ann Intensive Care"},{"key":"2110_CR71","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cmpb.2007.04.006","volume":"89","author":"J Lin","year":"2008","unstructured":"Lin J, Lee D, Chase JG, Shaw GM, Le Compte A, Lotz T, et al. Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput Methods Prog Biomed. 2008;89:141\u201352.","journal-title":"Comput Methods Prog Biomed"},{"key":"2110_CR72","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1515\/bmt-2016-0051","volume":"62","author":"JL Dickson","year":"2017","unstructured":"Dickson JL, Chase JG, Lynn A, Shaw GM. Model-based glycaemic control: methodology and initial results from neonatal intensive care. Biomed Tech (Berl). 2017;62:225\u201333.","journal-title":"Biomed Tech (Berl)"},{"key":"2110_CR73","doi-asserted-by":"publisher","first-page":"e012982","DOI":"10.1136\/bmjopen-2016-012982","volume":"7","author":"J Alsweiler","year":"2017","unstructured":"Alsweiler J, Williamson K, Bloomfield F, Chase G, Harding J. Computer-determined dosage of insulin in the management of neonatal hyperglycaemia (HINT2): protocol of a randomised controlled trial. BMJ Open. 2017;7:e012982.","journal-title":"BMJ Open"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-018-2110-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T05:52:21Z","timestamp":1604728341000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-2110-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2110"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-2110-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JGC has consulted for Medtronic and Monarch Medical. CDB is a consultant for Abbott, A. Menarini Diagnostics, Medtronic, and Roche Diagnostics. RH reports having received speaker honoraria from Eli Lilly, Novo Nordisk, and Astra Zeneca, serving on advisory panels for Eli Lilly and Novo Nordisk, receiving license fees from BBraun and Medtronic, and having served as a consultant to BBraun. JK is a consultant for Edwards, Medtronic, Roche Diagnostics, and Optiscan. J-CP is a consultant for Edwards, Medtronic, and Optiscan, and is an Associate Editor forCritical Care. The remaining authors declare that they have no conflicts of interest relevant to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"182"}}